Ignite Creation Date:
2025-12-24 @ 3:51 PM
Ignite Modification Date:
2026-01-29 @ 6:10 PM
Study NCT ID:
NCT00955292
Status:
TERMINATED
Last Update Posted:
2009-08-10
First Post:
2009-08-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Dose-escalation Study of Quarfloxin in Patients With Advanced Solid Tumors or Lymphomas
Sponsor:
Cylene Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
C3-07-002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
C. Padgett
Old Organization:
Cylene Pharmaceuticals